fluorouracil has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 19 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Subacute cutaneous lupus erythematosus is an uncommon dermatosis characterised by a non-scarring, annular photo-distributed dermatosis associated with anti-Ro/SSA antibodies." | 2.47 | [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review]. ( Bagot, M; Cosnes, A; Duong, TA; Gantzer, A; Ortonne, N; Regnier, S; Wolkenstein, P, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Shakhbazova, A | 1 |
| Marsch, AF | 1 |
| Cohen, PR | 1 |
| Borucki, R | 1 |
| Werth, VP | 1 |
| Baggio, R | 1 |
| Chavel, P | 1 |
| Tisseau, L | 1 |
| Darrieux, L | 1 |
| Safa, G | 1 |
| Hernandez-Aragues, I | 1 |
| Baniandrés-Rodríguez, O | 1 |
| Avilés-Izquierdo, JA | 1 |
| Vilas-Boas, PT | 1 |
| Miyagawa, F | 1 |
| Sugano, Y | 1 |
| Sho, M | 1 |
| Asada, H | 1 |
| Ko, JH | 1 |
| Hsieh, CI | 1 |
| Chou, CY | 1 |
| Wang, KH | 1 |
| Fongue, J | 1 |
| Meunier, B | 1 |
| Lardet, D | 1 |
| Dicostanzo, MP | 1 |
| Rouby, F | 1 |
| Terrier, JP | 1 |
| Harlé, JR | 1 |
| Richard, MA | 1 |
| Chiche, L | 1 |
| Kim, WI | 1 |
| Kim, JM | 1 |
| Kim, GW | 1 |
| Mun, JH | 1 |
| Song, M | 1 |
| Kim, HS | 1 |
| Kim, BS | 1 |
| Kim, MB | 1 |
| Ko, HC | 1 |
| Weger, W | 1 |
| Kränke, B | 1 |
| Gerger, A | 1 |
| Salmhofer, W | 1 |
| Aberer, E | 1 |
| Fernandes, NF | 1 |
| Rosenbach, M | 1 |
| Elenitsas, R | 1 |
| Kist, JM | 1 |
| Floristan, U | 1 |
| Feltes, RA | 1 |
| Sendagorta, E | 1 |
| Feito-Rodriguez, M | 1 |
| Ramírez-Marín, P | 1 |
| Vidaurrázaga, C | 1 |
| Casado-Jiménez, M | 1 |
| Almagro, BM | 1 |
| Steyls, MC | 1 |
| Navarro, NL | 1 |
| Domínguez, EG | 1 |
| Acosta, EH | 1 |
| Pérez, MA | 1 |
| Ceballos, EH | 1 |
| Gantzer, A | 1 |
| Regnier, S | 1 |
| Cosnes, A | 1 |
| Ortonne, N | 1 |
| Wolkenstein, P | 1 |
| Bagot, M | 1 |
| Duong, TA | 1 |
| Kindem, S | 1 |
| Llombart, B | 1 |
| Requena, C | 1 |
| Ruiz, A | 1 |
| Traves, V | 1 |
| Guillen, C | 1 |
| San Martin, O | 1 |
| Tsokos, GC | 1 |
| Yoshimasu, T | 1 |
| Nishide, T | 1 |
| Seo, N | 1 |
| Hiroi, A | 1 |
| Ohtani, T | 1 |
| Uede, K | 1 |
| Furukawa, F | 1 |
| Vogt, T | 1 |
| Coras, B | 1 |
| Hafner, C | 1 |
| Landthaler, M | 1 |
| Reichle, A | 1 |
| Dudley, K | 1 |
| Micetich, K | 1 |
| Massa, MC | 1 |
2 reviews available for fluorouracil and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
Topics: Age Distribution; Aged; Antimetabolites, Antineoplastic; Capecitabine; Female; Fluorouracil; Humans; | 2019 |
[Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Topics: Adenocarcinoma; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2011 |
17 other studies available for fluorouracil and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Chronic cutaneous lupus erythematosus induced by 5-fluorouracil.
Topics: Deoxycytidine; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous | 2020 |
Response letter to 'chronic cutaneous lupus erythematosus induced by 5-fluorouracil'.
Topics: Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid | 2020 |
[Subacute cutaneous lupus erythematosus induced by 5-fluorouracil].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Car | 2017 |
Cutaneous Drug REactions: Annular, polycyclic erythematous exanthema in an oncology patient.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2017 |
TS-1 (tegafur/gimeracil/oteracil)-induced systemic lupus erythematosus with skin lesions and anti-Sm antibody.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Therapy, Combination; Fluo | 2017 |
Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lu | 2013 |
[Capecitabine-induced subacute cutaneous lupus: a case report].
Topics: Adverse Drug Reaction Reporting Systems; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neop | 2014 |
Subacute cutaneous lupus erythematosus induced by capecitabine: 5-FU was innocent.
Topics: Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Female; Fluorouracil; Humans; Lupus Er | 2016 |
Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Topics: Acute Disease; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytid | 2008 |
Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lupus Er | 2009 |
Subacute cutaneous lupus erythematosus induced by capecitabine.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Erupt | 2009 |
Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorouracil; Heart Diseases; Humans; Lupus Ery | 2011 |
Subacute cutaneous lupus erythematosus after treatment with capecitabine.
Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluoro | 2013 |
Drugs, sun and T cells in lupus.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autoantibodies; Dermatitis, Photoallergic; Drug Hypersens | 2004 |
Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Fluorouracil; Gene Deletion; Genes | 2004 |
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes.
Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Capecit | 2006 |
Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5-fluorouracil.
Topics: Aged; Dermatitis, Seborrheic; Erythema; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Male; | 1987 |